Edap Tms (EDAP) Competitors

Edap Tms (NASDAQ:EDAP) and AVITA Medical (NASDAQ:RCEL) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, community ranking, valuation, earnings, profitability, institutional ownership, media sentiment, risk and dividends.

Which has more risk and volatility, EDAP or RCEL?

Edap Tms has a beta of 0.12, suggesting that its stock price is 88% less volatile than the S&P 500. Comparatively, AVITA Medical has a beta of 1.6, suggesting that its stock price is 60% more volatile than the S&P 500.

Does the media prefer EDAP or RCEL?

In the previous week, AVITA Medical had 1 more articles in the media than Edap Tms. MarketBeat recorded 4 mentions for AVITA Medical and 3 mentions for Edap Tms. AVITA Medical's average media sentiment score of 0.47 beat Edap Tms' score of 0.30 indicating that AVITA Medical is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Edap Tms	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
AVITA Medical	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Which has stronger valuation and earnings, EDAP or RCEL?

Edap Tms has higher earnings, but lower revenue than AVITA Medical. AVITA Medical is trading at a lower price-to-earnings ratio than Edap Tms, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Edap Tms	$64.12M	0.82	-$22.92M	-$0.55	-2.58
AVITA Medical	$64.25M	3.82	-$61.85M	-$2.39	-3.92

Is EDAP or RCEL more profitable?

Edap Tms has a net margin of -34.92% compared to AVITA Medical's net margin of -96.26%. Edap Tms' return on equity of -44.21% beat AVITA Medical's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Edap Tms	-34.92%	-44.21%	-25.88%
AVITA Medical	-96.26%	-337.91%	-71.50%

Do analysts rate EDAP or RCEL?

Edap Tms presently has a consensus price target of $8.50, suggesting a potential upside of 499.86%. AVITA Medical has a consensus price target of $17.25, suggesting a potential upside of 84.29%. Given Edap Tms' higher probable upside, analysts plainly believe Edap Tms is more favorable than AVITA Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Edap Tms	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.67
AVITA Medical	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Do insiders and institutionals have more ownership in EDAP or RCEL?

62.7% of Edap Tms shares are owned by institutional investors. Comparatively, 27.7% of AVITA Medical shares are owned by institutional investors. 0.2% of Edap Tms shares are owned by insiders. Comparatively, 1.8% of AVITA Medical shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Does the MarketBeat Community prefer EDAP or RCEL?

Edap Tms received 266 more outperform votes than AVITA Medical when rated by MarketBeat users. However, 70.34% of users gave AVITA Medical an outperform vote while only 60.91% of users gave Edap Tms an outperform vote.

Company	Underperform	Outperform
Edap Tms	Outperform Votes 349 60.91%	Underperform Votes 224 39.09%
AVITA Medical	Outperform Votes 83 70.34%	Underperform Votes 35 29.66%

Summary

Edap Tms and AVITA Medical tied by winning 9 of the 18 factors compared between the two stocks.